GEO DataSets

Analysis of SW480 cancer cells treated with tankyrase inhibitor, MEK inhibitor, or both, for up to 16hrs. Dual inhibition of TNKS and MEK led to tumor regression. Results provide insight into molecular mechanisms underlying the synergistic effects of TNKS and MEK inhibitors in KRAS-mutant cancers.

Organism:

Homo sapiens

Type:

Expression profiling by array, count, 5 protocol, 3 time sets

Platform:

GPL570

Series:

GSE55624

18 Samples

Download data: CEL